Search

Thursday 25 July 2024

HeraMED (ASX:HMD): Soft launches HERAcare by Telstra Health

HeraMED Limited (ASX: HMD) , a medical data and technology company leading the digital transformation of maternity care, today announces the soft launch of HeraCARE within the Telstra Health ecosystem through targeted GP clinics. In November 2023, HeraMED announced its partnership with Telstra Health’s MedicalDirector platform servicing GP and healthcare professionals and is the first remote maternity solution to join the Telstra Health digital ecosystem.

The soft launch of HeraCARE into Telstra Health’s Smart Connected Care was recently announced at the RACGP Practice Owners Conference in Cairns, Australia. The initial step in the commercial rollout will be focussing on recruiting the first group of GP clinics (or ‘early adopters’) as part of the integration of HeraCARE into MedicalDirector, GP workflows while optimising care models, and commercial models while gathering overall feedback from the Beta Program before a full launch to the larger network.

On completion of the soft launch, HeraMED anticipates marketing to the entire GP clinic customer base and onboarding of mums through Telstra Health’s GP clinics practices by the end of calendar year 2024. HeraMED and Telstra Health will also jointly promote the integration of HeraMED into the Smart Connected Care ecosystem through education and marketing to existing and prospective users as part of the Smart Partner Marketing Plan.

Highlights:

● In November 2023, HeraMED initially announced its partnership with Telstra Health’s MedicalDirector platform servicing GP and healthcare professionals. 1 HeraCARE is the first remote maternity solution to join the Telstra Health digital ecosystem;

● A soft launch was recently announced by Telstra Health at the Royal Australian College of General Practitioners (RACGP) Practice Owners Conference held in Cairns, Australia2 ;

● On completion of the soft launch, HeraMED is targeting the onboarding of mums through Telstra Health’s extensive GP customer base by the end of calendar year 2024;

● This partnership with Telstra Health supports HeraMED’s commercialisation strategy to target the GP vertical which plays a significant role in maternity, both prenatal and postpartum, to enhance the user’s maternity experience.

Commentary:

HeraMED CEO Anoushka Gungadin confirmed, “HeraCARE is a mum-centric solution and the partnership with Telstra Health allows us to expand access to care for many more mums, given the significant role GPs play in maternity, pregnancy and postpartum care. Following integration and commercial rollout within this new ecosystem, we are targeting the onboarding of mums through GP practices by the end of calendar year 2024. This aligns with the four-point plan both for commercialisation and strategic partnership while redefining how maternity care is delivered and experienced.”

ASX announcement: 

Free stock updates

Subscribe to receive the latest stock news, CEO interviews, expert insights, events and offers directly into your inbox